The Sixth European Biotechnology Symposium November 13 - 15, 2005;
Competitive Biotechnology: Advanced Biologics Manufacturing and
Closing the Deal: Joint Ventures and Partnership

NEW ROCHELLE, N.Y.-- -- Aug. 9, 2005--Senior managers of
biopharmaceutical and pharmaceutical companies with responsibility
for biopharmaceutical product development, manufacture, regulatory
compliance and quality assurance, along with senior representatives
of companies providing services and support to biopharmaceutical
firms and major pharma will assemble at the Radisson SAS Scandinavia
Hotel in Copenhagen for the Sixth European Biotechnology Symposium.

Organized by BioConferences International, Inc., in cooperation with
GENETIC ENGINEERING NEWS, this symposium provides an opportunity to
gain a pan-European view of the industry and its business
environment and provides a forum for discussing biopharmaceutical
manufacturing for pharmaceutical and biotechnology companies in
Europe, from the USA, Canada and rest of the world, and fosters
opportunities for global marketing.

The opening plenary, Mammalian Cell Culture Processes for Large
Scale Operation from DNA to Product by Florian M. Wurm, PhD, Prof.
of Biotechnology, Swiss Federal Institute of Technology, Lausanne,
Switzerland, will help set the overall tone for the conference. Also
this year, with the addition of the Doing the Deal session, we will
have Gitte Pedersen, Special Advisor, Invest in Denmark introducing
the deal session with Linda Powers Managing Partner, Toucan Capital,
Bethesda, MD, Eric Halioua, Senior Manager, Arthur D. Little,
Boston, MA, Jesper Zeuthen, D.Sc. Managing Director, BanInvest
Group, Copenhagen, as well as Linda Horton, Regulatory Law Partner,
Hogan & Harrison, Washington, DC. The business perspectives provided
by these financial experts will complement the scientific and
technical presentations from the other speakers.

The conference offers many networking opportunities commencing with
an opening reception in the expo hall on Sunday evening, November
13, at the Radisson SAS Scandinavia Hotel, Copenhagen. Then Monday
and Tuesday continental breakfast, lunch and two networking
coffee/tea breaks will be in the expo area, giving delegates and
presenters an opportunity for networking prior to and in-between the
sessions. There is also a Monday evening Gala reception planned in
the Casino Ballroom. This offers an excellent backdrop for
networking, and collaborations for global marketing. There are
poster sessions in the expo hall as well. The meeting hall is right
next to the exhibit area and the posters, making everything very
accessible.

The Symposium, which begins Monday, November 14, uniquely addresses
biotech's two principal concerns, technology and business, through
two consecutive tracks. "Competitive Biotechnology: Advanced
Biologics Manufacturing" (morning and afternoon, November 14 and
morning of November 15) features leading European experts in
biomanufacturing.

Sponsors for the Sixth European Biotechnology Symposium include Host
Sponsor: Invest in Denmark, Chairs Cup: Pall Life Sciences,
Platinum: Sartorius, Diamond: Novozymes, Gold: Hyclone and Silver:
Stedim, CMC, Toucan Capital, Linde, Charles River, Cambrex,
Strathmann Biotec AG and BioKnex. Additional opportunities for
sponsorships and exhibitors and poster presenters are available.

Arizona Biotech

Biotech News

Arizona Entrepreneurs

Arizona High Tech